Skip to main content

JDRF has now rebranded to Breakthrough T1D.
Our name has changed, our mission has not.

Research

Genetically unique siblings reveal new treatment target for type 1 diabetes

Two siblings who have unique changes in a key gene have given researchers new insights that could help lead to innovative new treatments in type 1 diabetes.
Breakthrough T1D profile picture
Josie Clarkson 18 April 2024
Content last reviewed and updated: 11.09.2024

Two young siblings hugging

There are lots of genes that are associated with an increased risk of developing type 1 diabetes. Studying these genes can provide researchers with new ideas for treatments for type 1, so the University of Exeter offers free worldwide screening for babies diagnosed with type 1 before they are 9 months old.

A unique genetic difference

New research from University of Exeter, co-funded by JDRF and published in the Journal of Experimental Medicine, studies two siblings who were diagnosed with a rare genetic form of autoimmune diabetes in the first weeks of life. Autoimmunity is where the immune system attacks our body’s own cells – in this case, the insulin-making beta cells.

The changes in their genes (known as a genetic mutation) have not been found in anyone else. The siblings’ mutation is in the gene for a protein called programmed death-ligand 1 (PD-L1) and the researchers think it could be responsible for their very-early-onset autoimmune diabetes.

Insights from cancer therapy

Some cancer patients are treated with a type of immunotherapy that stops PD-L1 from working. These people can develop autoimmune diabetes because of the treatment. We don’t know why only this cancer immunotherapy triggers autoimmune diabetes. The siblings’ genetic mutation results in the same effect as the cancer treatment, shedding new light on the involvement of PD-L1 in type 1 diabetes.

A new research avenue

Study co-author Professor Timothy Tree, from King’s College London, said: “This finding increases our knowledge of how autoimmune forms of diabetes such as type 1 diabetes develop. It opens up a new potential target for treatments that could prevent diabetes in the future. Simultaneously, it gives new knowledge to the cancer immunotherapy field by uniquely providing the results of completely disabling PD-L1 in a person, something you could never manipulate in studies. Reducing PD-L1 is already effective for cancer treatment, and boosting it is now being investigated as a type 1 diabetes treatment – our findings will help accelerate the search for new and better drugs.”

Next steps for the research

“Through studying this one set of siblings – unique in the world to our knowledge – we have found that the PD-L1 gene is essential for avoiding autoimmune diabetes but is not essential for ‘everyday’ immune function. This leads us to the grand question; ‘what is the role of PD-L1 in our pancreas making it critical for preventing our immune cells destroying our beta cells?’ We know that under certain conditions beta cells express PD-L1. However, certain types of immune cells in the pancreas also express PD-L1. We now need to work out the communication between different cell types that is critical for preventing autoimmune diabetes.”

Learn about another of Professor Tim Tree’s JDRF-funded research projects.

More research news

Read more
Dr Ana Cruz in her lab
Research
8 January 2025

Breakthrough in T1D treatment: Engineered islets produce insulin without immunosuppression

Sana Biotechnology, a US-based biotech company, has released clinical data showing that the first person receiving engineered islets from deceased donors is now producing insulin without the need for immunosuppressive drugs.

Read more
Mum and daughter wearing Breakthrough T1D t-shirts and holding a flag in a park.
News
16 December 2024

Research and policy breakthroughs in 2024

Our highlights from a year full of breakthroughs in type 1 diabetes research and advocacy.

Read more
Researcher with microscope
Research
13 December 2024

Breakthrough T1D funds four new type 1 diabetes research projects in the UK

We’ve awarded four new grants to UK researchers to help improve lives and develop cures for people living with type 1 diabetes.

Read more
A photograph of two women. The woman on the right is a healthcare professional who has a hand on the other woman's arm.
Research
12 November 2024

New policy framework launches to improve sex and gender data in UK research

The framework aims to encourage UK researchers to consider different sexes (biological attributes) and genders (roles, behaviours and identity in society) to address gaps in health data.